Related by context. All words. (Click for frequent words.) 80 Inhibits 78 Lowers Risk 78 Prolongs Survival 77 Orally Active 76 Anti Tumor 76 Antitumor 76 Drug Candidate 76 Modulates 76 Effectively Treats 76 Induces 76 Levels Linked 76 Shows Promise Against 76 Meets Primary Endpoint 75 Shows Promising 75 Treating Chronic 75 Am J Clin 75 Skeletal Muscle 75 Suppresses 75 Mouse Model 75 Recombinant Human 75 Immune Responses 75 Therapy Improves 75 Hypertensive Patients 75 Improves Survival 74 Dehydrogenase 74 Demonstrates Efficacy 74 Lanthanum Carbonate 74 Dendritic Cells 74 Lowers Blood Pressure 74 Antitumor Activity 74 Receptor Agonist 74 Study Casts Doubt 74 Anti Tumor Activity 74 Novel Oral 74 Oral Fingolimod 74 Tocopherol 73 Reduces Risk 73 Anti Inflammatory 73 Reductase 73 Clinical Outcome 73 Therapeutic Efficacy 73 Phase 2b Trial 73 Drug Shows Promise 73 Pharmacodynamics 73 Novel Inhibitor 73 Adenoviral 73 Fibrinogen 73 Appears Safe 73 Signaling Pathway 73 Kinase Inhibitor 73 Uric Acid 73 Cancer Cells 73 Controlled Trial 73 Breast Cancer Cells 73 Study Evaluating 73 Polymorphisms 73 AnaSpec Introduces 73 Diabetic Nephropathy 73 Protein Linked 73 Inhaled Corticosteroids 73 Soy Isoflavones 73 Neurotoxicity 73 Impairs 73 Thiazolidinediones 73 Drug Prevents 72 Sustained Release 72 Hormone Refractory Prostate Cancer 72 Mimetics 72 Shows Efficacy 72 Gene Variant 72 Drug Resistant 72 Completes Patient Enrollment 72 Inflammatory Markers 72 Improves Outcomes 72 Tumor Growth 72 Novel Mechanism 72 Single Dose 72 Pooled Analysis 72 Mouse Models 72 Slow Progression 72 Stress Induced 72 Tyrosine Kinase Inhibitor 72 Liver Injury 72 Postmenopausal Women 72 #-# Full Text 72 Nicotine Vaccine 72 FDA Okays 72 Investigational Compound 72 Mg Uk 72 Clinical Trial Results 72 Calcification 72 Receives Orphan Drug Designation 72 Previously Treated 72 Int J 72 Meta Analysis 72 Autoantibodies 72 Low Dose 72 Cannabinoid 72 Kidney Function 72 Adjuvant Chemotherapy 72 Genes Linked 72 Phase 2b Clinical Trial 72 Protein Involved 72 Peginterferon Alfa 2a 72 Nat Clin Pract 72 Secretion 72 Progenitor Cells 72 Intracellular 72 Neurol 72 Nucleoside 72 Smooth Muscle 72 Immunomodulatory 72 Knee Osteoarthritis 72 Curr Opin 72 Novel Method 72 Gene Variants 71 IND Application 71 Cholesterol Lowering 71 Phospholipase A2 71 Mg Usa 71 Blood Pressure Drug 71 Critically Ill Patients 71 Premenopausal Women 71 FDA Warns Against 71 Eur J 71 Phase 2a Clinical Trial 71 Protease Inhibitor 71 Gene Linked 71 Transdermal Patch 71 Chronic Hepatitis C 71 Therapeutic Potential 71 Bone Metastases 71 Immune Cells 71 Cyclooxygenase 2 71 Therapy Reduces 71 Improve Survival 71 Preclinical Data 71 Protease Inhibitors 71 Antigen Specific 71 Test Detects 71 Holds Promise 71 Lowers Cholesterol 71 Synthase 71 Unfractionated Heparin 71 Adjuvant Treatment 71 Study Shows Benefits 71 Phase 2a Trial 71 Could Predict 71 Phase IIa Clinical Trial 71 Amniotic Fluid 71 J Am Coll 71 Presents Preclinical Data 71 CYP#A# CYP#D# 71 Statistically Significant 71 Hepatitis C Genotype 71 Slows Progression 71 Potentially Fatal 71 Endothelial Cells 71 Complicated Skin 71 Genetic Variation 71 Transdermal Delivery 71 Cell Adhesion 71 Inhibit 71 Treatment Reduces 71 Tumor Targeting 71 Endocrinol 71 Allogeneic 71 #:#-# [023] 71 Epidermal Growth Factor Receptor 71 Increases Risk 71 Thrombotic 71 See CLINICAL PHARMACOLOGY 71 Diabetic Neuropathy 71 Atypical Antipsychotic 71 Chronic Renal Failure 71 Glucocorticoid 71 Crit Rev 71 Receptor Antagonist 71 Severe Sepsis 71 Patients Treated With 71 Renal Cell Carcinoma 71 Beneficial Effects 71 Lymphoid 71 Factor Receptor 71 Refractory Hodgkin Lymphoma 71 Fracture Risk 71 Parathyroid Hormone 71 Skin Disorders 71 Cell Proliferation 71 Genetic Mutation 71 Pharmacokinetic Study 71 Significantly Reduces 71 Patients Undergoing 71 Statin Drugs 71 Elderly Patients 71 Dose Response 70 Systemic Delivery 70 Could Prevent 70 Abdominal Fat 70 Gene Variation 70 Placebo Controlled Trial 70 Molecular Mechanism 70 Pathol 70 Spinal Fluid 70 Increased Mortality 70 Shows Promise 70 Fungal Infections 70 Inflammatory Arthritis 70 Artery Disease 70 Gene Mutation 70 Breast Cancer Recurrence 70 Leukemia Cells 70 Oxidative Stress 70 Thyroid Function 70 Epilepsy Drugs 70 Synaptic Plasticity 70 Double Blind Randomized 70 Naturally Occurring 70 Conjugated 70 Diabetic Foot Ulcer 70 Biosynthesis 70 Angiogenic 70 Long Term Efficacy 70 Anticancer Drug 70 Prolongs Life 70 Blood Clotting 70 Prognostic Factors 70 Proves Effective 70 Dose Finding 70 Reduce Inflammation 70 Adipose Tissue 70 Cocaine Addiction 70 Cerebrospinal Fluid 70 Thyroid Hormone 70 J Clin 70 Submits NDA 70 Premature Aging 70 Antifungal 70 Digestive Tract 70 Vitro Activity 70 Excretion 70 Lipid Levels 70 Demonstrates Significant 70 Secretase 70 Shown Effective 70 Reduced Risk 70 Data Suggest 70 FDA Clears 70 Poorly Controlled 70 J Pediatr 70 Helps Prevent 70 Carcinomas 70 Demonstrates Positive 70 Novel Therapeutic 70 Adenoma 70 Radiofrequency Ablation 70 Postdoctoral Position 70 Reduces Pain 70 Clinical Efficacy 70 Inactivation 70 Septic Shock 70 Monoclonal Antibody 70 Protein Synthesis 70 Prostate Tumors 70 Aurora Kinase 70 Eases Pain 70 Elevated Levels 70 Drug Fails 70 Patients Receiving 70 Teva Provides Update 70 Randomized Phase II 70 Study Proves 70 Left Ventricular 70 Potent Inhibitor 70 Initiates Clinical Trial 70 Polymerase Inhibitor 70 Ovarian Cancers 70 Tumor Suppressor Gene 70 Neurotransmitter 70 Amino Acid 70 Phase 2b Study 70 Endothelial Function 70 Trial Evaluating 70 Small Molecule 70 Demonstrated Significant 70 Virus Linked 70 Interferon Beta 70 Anti Inflammatory Drug 70 Tiotropium 70 Sex Hormones 70 Predict Response 69 Novel Treatments 69 Drug Combo 69 Files IND 69 Hematological Cancers 69 Prophylactic Treatment 69 Polymorphism 69 Hypercholesterolemia 69 Present Preclinical Data 69 Receptor Antagonists 69 Soluble CD# 69 Develop Novel 69 FDA Approves Drug 69 Preclinical Study 69 Stomach Cancer 69 FDA Approvals 69 Obesity Linked 69 Prevent Breast Cancer 69 Treated Patients 69 Well Tolerated 69 Confirmatory Phase 69 Presents Positive 69 Molecular Basis 69 Chemotherapeutic Agents 69 Angiotensin 69 Subunit 69 Dose Ranging Study 69 Reduces Mortality 69 Low Doses 69 Cardiac Function 69 Exposure Linked 69 Demonstrates Potent 69 Soft Tissue Sarcoma 69 Insulin Resistance 69 Liver Tumors 69 Relapsing Multiple Sclerosis 69 Advanced Colorectal Cancer 69 Oral Cavity 69 Neurosurg 69 Oxidative 69 Hematopoietic Stem Cells 69 Pediatric Patients 69 #:#-# [037] 69 FDA Accepts 69 Phase IIb Trial 69 Rheumatoid Arthritis Patients 69 Could Detect 69 Homeostasis 69 Insulin Sensitivity 69 Inhibitory 69 Significantly Improved 69 Antithrombin 69 Anticancer Activity 69 Combo Therapy 69 Abstract Full Text 69 Gastric Cancer 69 Intracerebral 69 Myeloid 69 Secondary Hyperparathyroidism 69 Pre Cancerous 69 Osteoporosis Drug 69 Proteasome 69 Clinical Trial Evaluating 69 Dietary Fiber 69 Interferon Gamma 69 Cholesterol Lowering Drug 69 Rheumatoid Arthritis Drug 69 Vaccine Shows Promise 69 Demonstrates Statistically Significant 69 Non Invasive Treatment 69 Subtypes 69 Randomized Study 69 Combination Treatment 69 Diabetic Patients 69 Histone 69 Contrast Agents 69 Aptamer 69 Hsp# Inhibitor 69 Electrical Stimulation 69 Resistant Hypertension 69 Predict Risk 69 Prostate Cancer Vaccine 69 Investigational Treatment 69 Antiviral Therapy 69 Plasmid DNA 69 Conjugate 69 Prognostic Value 69 Metabolites 69 Calcium Vitamin D 69 JAK Inhibitor 69 Breast Cancer Metastasis 69 Humanized Anti 69 Successfully Completes Phase 69 Cell Transplants 69 Phosphorylation 69 Significantly Improves 69 Aggressive Prostate Cancer 69 Superoxide 69 Myeloma Patients 69 Tegretol carbamazepine 69 Epithelial 69 Postprandial 69 Hematopoietic 69 Hepatitis B Virus 69 Synthetic Peptide 69 Epilepsy Drug 69 J Am Soc 69 Radiation Induced 69 Methylprednisolone 69 Arch Facial Plast 69 Initiate Phase 69 Protein Expression 69 Reperfusion Injury 69 Phase Ib Clinical Trial 69 Relapsed Refractory 69 Antiviral Activity 69 Inflammatory Response 69 Disord 69 Osteoporosis Treatment 69 Differentially 69 Increased Risk 69 Disease Progression 69 Pharmacokinetics PK 69 Selective Inhibitor 69 Adverse Effects 69 Blood Thinner 69 Arterial Disease 69 Beta Blocker 69 Anticoagulant 69 Receptor Signaling 69 Alanine 69 Muscle Wasting 69 Pharmacologic 69 Survival Benefit 69 Antibiotic Resistant 69 Endocrinol Metab 69 Antidepressants Linked 69 Susceptibility Testing 69 Murine Model 68 Pramlintide 68 Contrast Agent 68 Cigarette Smoke 68 Novel Antibiotic 68 Malignant Glioma 68 Ultrasensitive 68 Wound Dressings 68 Controlled Study 68 Extracellular Matrix 68 Fewer Side Effects 68 Effective Treatments 68 Menopausal Symptoms 68 Novel Compound 68 Mucosal 68 ACE Inhibitors 68 Posaconazole 68 Extracellular 68 Therapeutic Effects 68 Demonstrates Potential 68 Node Positive 68 Skin Lesions 68 Endothelial 68 Oncolytic Reovirus 68 Muscle Cells 68 Localized Prostate Cancer 68 Clin J 68 Genetic Variant 68 Proliferative 68 Topical Treatment 68 Advanced Melanoma 68 Coronary Arteries 68 NMDA Receptor 68 Castration Resistant Prostate Cancer 68 Diet Linked 68 Obese Patients 68 Oral Insulin 68 Leukemias 68 Signaling Pathways 68 Salivary 68 Prostatic 68 Secretory 68 Treatment Naïve 68 HER2 Positive 68 Migraine Drug 68 3 Fatty Acids 68 Nephrol 68 Helps Relieve 68 Retinoic Acid 68 Gout Drug 68 Help Detect 68 Initiates Phase II 68 Study Showed 68 Osteoporosis Drugs 68 Toxicol 68 Androgen Receptor 68 Is Well Tolerated 68 Leukocyte 68 Itraconazole 68 Androgen 68 Therapeutic Competitors Report 68 Combination REOLYSIN R 68 Cognitive Decline 68 Free Full Text 68 Protease 68 Oral Calcitonin 68 HER2 Positive Breast Cancer 68 Neuroprotection 68 Fixed Dose 68 Bosutinib 68 Chronic Inflammation 68 Investigational Drug 68 Immune Cell 68 Genes Associated 68 Predict Prostate Cancer 68 J Child Adolesc 68 Suppl. 68 Viral Load 68 Genes Predict 68 Infected Patients 68 Hormone Receptor Positive 68 Lung Cancer Risk 68 Blood Pressure Drugs 68 Pediatr 68 Beta Amyloid 68 Br J 68 Successfully Treated 68 Liver Failure 68 Tumor Cell 68 Liver Damage 68 Postmenopausal Osteoporosis 68 Safinamide 68 CYP#A# substrate 68 Blood Vessels 68 Neovascular Age Related Macular 68 Phase IIb Clinical Trial 68 Long Term Survival 68 Anti Angiogenic 68 TNF Blockers 68 Prognostic Significance 68 Quantitation 68 Adjunctive Therapy 68 Diagnostic Tests 68 Phase III Clinical Trial 68 Breast Tissue 68 downregulates 68 Commences Phase 68 Often Misdiagnosed 68 Antisense Oligonucleotides 68 Polyethylene Glycol 68 Systematic Review 68 Antiviral Drugs 68 Treatment Shows Promise 68 Completes Enrollment 68 Estrogen Receptor 68 Chimeric 68 Randomized Double Blind 68 Urinary Tract 68 Non Alcoholic Steatohepatitis 68 Plaque Psoriasis 68 Colorectal Cancer Risk 68 Nutr 68 Patients Suffering 68 Human Monoclonal Antibody 68 Chronic Sinusitis 68 Improved Survival 68 Being Studied 68 Treatment Resistant 68 Ovarian Cancer Risk 68 Respiratory Virus 68 Allergic Reactions 68 Gene Mutations 68 Platelet Derived Growth 68 Carotenoid 68 Tubulin 68 Int J Obes Relat 68 Monotherapy 68 Immunogenicity 68 Tumor Suppressor 68 Subgroup Analysis 68 Safety Tolerability 68 J Shoulder Elbow 68 Dose Escalation 68 Enlarged Prostate 68 Insulin Glargine 68 Nilotinib 68 Hepatic Encephalopathy 68 Prove Effective 68 Vitamin D Linked 68 Fast Skeletal Troponin 68 Recurrent Breast Cancer 68 Inflammatory Diseases 68 Monoclonal 68 Prospective Randomized 68 Preclinical Efficacy 68 Annu Rev 68 Transcriptional 68 Erythropoietic 68 Hepatic 68 Squamous Cell Carcinoma 68 Somatostatin 68 Fondaparinux 68 Inflammatory Pain 68 Lung Cancer Drug 68 Brain Shrinkage 68 Prenatal Exposure 68 Kidney Transplant Patients 68 Receives Approvable Letter 67 Bile Acid 67 Alkaline Phosphatase 67 Long Lasting 67 Immunol 67 Cancer Incidence Mortality 67 Brain Cells 67 Circulating Tumor Cells 67 Brain Function 67 Chronic Bronchitis 67 Newly Diagnosed Multiple Myeloma 67 Peginterferon 67 Bacterial Infection 67 Protein Kinase 67 Study Shows Promise 67 Relapsing Remitting Multiple Sclerosis 67 Autologous Stem Cell Transplantation 67 dopamine D2 67 Initiates Phase III 67 Significantly Reduced 67 Phosphatase 67 Cardiac Troponin 67 Tesamorelin 67 FOR WELL BEING 67 platform HDL Mimetic 67 Allergic Rhinitis 67 Benign Prostatic Hyperplasia 67 Vildagliptin 67 Peptic Ulcer 67 Randomized Double blind 67 Previously Untreated 67 Endoplasmic Reticulum 67 TO AVOID PREGNANCY WHILE 67 NDA Submission 67 Naive Patients 67 Male Contraceptive 67 Arch Neurol 67 Predict Breast Cancer 67 Endovascular Treatment 67 Minimally Invasive Treatment 67 Initiates Clinical 67 Haemophilus b Conjugate 67 Streptococcus agalactiae 67 Cytochrome P# 67 Tumor Cells 67 Develops Novel 67 Strongly Linked 67 Mol Cell 67 Chromium Picolinate 67 J Am Acad 67 palmitoyl 67 Physiol 67 Iron Overload 67 Transcription Factor 67 Hematological 67 Statins Reduce 67 Diagnostic Criteria 67 Medoxomil 67 Chemotherapy Induced 67 Patent Covering 67 Lupus Drug 67 Antiangiogenic 67 Intracranial Aneurysms 67 Neoplasms 67 Iron Deficiency 67 Maleate 67 Renal Artery 67 Relieves Pain 67 Sleep Disturbances 67 Breast Cancer Stem Cells 67 #:#-# [031] 67 Glucose Levels 67 Weight Loss Supplement 67 Antipsychotic 67 Replacement Therapy 67 Further Validates 67 Cancer Res 67 Angiotensin II 67 Chronic Hepatitis B 67 Subtype 67 Cardiovascular Disease Risk 67 Showed Significant 67 Sulfonylurea 67 Cognitive Impairment 67 Bone Marrow Cells 67 Multicenter Trial 67 Renal Function 67 Biotechnol 67 Rotavirus Vaccine 67 Mylan Receives Approval 67 Pegylated 67 Announces FDA Clearance 67 Investigational Agent 67 Blood Flow 67 J Appl 67 Fat Cells 67 Myelodysplastic Syndromes 67 Neoadjuvant Chemotherapy 67 Experimental Vaccine 67 Prevent Prostate Cancer 67 ACER paper 67 Overactive Bladder 67 II Clinical Trial 67 Vaccine Prevents 67 Vascular Inflammation 67 RNAi Therapeutic 67 Malignancy 67 Tyrosine Kinase 67 Diabetic Kidney Disease 67 Glycosylation 67 Transcriptome 67 Cognitive Deficits 67 Myocardial Ischemia 67 JAK2 Inhibitor 67 IN PATIENTS WITH 67 Ischemic 67 Lipase 67 Modulating 67 Inj 67 Randomized Double Blind Placebo 67 Neovascularization 67 Aortic Valve 67 Genetic Marker 67 Advanced Ovarian Cancer 67 Commonly Used 67 J Allergy Clin 67 Hepatocellular 67 Incretin 67 Genes Involved 67 mediated inhibition 67 CAS #-#-# Market [001] 67 Glatiramer Acetate 67 Provides Clues 67 Treat Anemia 67 Vertebral Fractures 67 Immunosuppression 67 Prolongs 67 Menstrual Pain 67 Healthbeat Report 67 Renal Cancer 67 calcitonin gene related 67 Dose Escalation Study 67 Lung Cancer Patients 67 Dosage Form 67 Analogs 67 matrix metalloproteases 67 Device Helps 67 Researchers Uncover 67 Bone Fractures 67 Lymphocytic 67 FDA Cracks Down 67 Antihypertensive 67 Efficacious 67 Tezampanel 67 Viral Infections 67 Bone Mineral Density 67 First Patient Dosed 67 Double Blind Placebo 67 Vaccine Adjuvants 67 Derived Stem Cells 67 Endometrial 67 Lower Blood Pressure 67 itraconazole Sporanox 67 Hedgehog Pathway 67 Interferon gamma 67 Proton Pump Inhibitors 67 Cytotoxicity 67 Immunologic 67 Plus Ribavirin 67 Chronic HCV 67 Breast Tumors 67 Drug Combinations 67 Mycophenolate Mofetil 67 Biol 67 Oncolytic 67 Antisense Drug 67 Lung Tumors 67 Biomolecules 67 Gastrointestinal Tract 67 Assay Kits 67 Oncol 67 D aspartic acid 67 Stent Restenosis 67 Antigens 67 Significant Reduction 67 Cholesterol Levels 67 Clinically Significant 67 Lyophilized 67 Can Detect 67 Genetic Markers 67 J Consult Clin 67 See WARNINGS 67 phosphatidylinositol 3 67 Oncogenic 67 Pulmonary Arterial Hypertension 67 Osteoarthritis Pain 67 Renal Cell Cancer 67 Clinical Implications 67 Therapeutic Antibody 67 Transmembrane 67 Activator CK # 67 Blood Pressure Lowering 67 Study Reinforces 67 Randomized Phase 67 Treatment Naïve Patients 67 Inhaled Liposomal Ciprofloxacin 67 Conjugates 67 Benzyl 67 Non Responders 67 Metabolic Disorder 67 TNF Tumor Necrosis Factor 67 ORLive Presents 67 Rolled Glass 67 Lactic Acid 67 Motility 67 Aldosterone 67 Triglyceride 67 Osteoarthritis Patients 67 Proc Am Soc 67 Generic Versions 67 Proven Effective 67 Genetic Variations 67 Primary Hypercholesterolemia 67 Anthracycline 67 Macrophage 67 CrossRef Medline 67 Shoulder Prosthesis 67 Diabetic Foot Ulcers 67 Vasc 67 Tigecycline 67 PRN FDA Approves 67 Cardiotoxicity 67 Microbiol 67 INDUSTRY ASSESSMENTS 67 Disease Causing 67 Nucleotide 67 Study Sheds Light 67 Muscarinic 67 Helps Identify 67 Aliskiren 66 Heart Failure Patients 66 Anticancer Agent 66 Detect Cancer 66 Prolactin 66 Disease Modifying 66 Brain Metastases 66 Potent Antiviral Activity 66 Antioxidant Supplements 66 Dry Powder Inhalers 66 Anticancer Drugs 66 Adjuvant Therapy 66 Blood Clot Risk 66 B Cell Lymphoma 66 Circadian Clock 66 Induces Apoptosis 66 Antiplatelet 66 HDAC Inhibitor 66 Multiple Myeloma Patients 66 Non Ferrous Alloys 66 Efficacy Trial 66 BioElectronics Announces 66 CAS #-#-# Market [002] 66 Eradicates 66 Scientists Uncover 66 Inhaled Nitric Oxide 66 Underlies 66 Phase 1b Clinical Trial 66 Seasonal Influenza Vaccine 66 Study Demonstrates 66 Randomized Trials 66 Peripheral Arterial 66 Azacitidine 66 prostaglandin E 66 Gene Silencing 66 Anti Nausea 66 Therapeutic Targets 66 Sustained Efficacy 66 Chemokine Receptor 66 Epithelial Cell 66 Hepatitis Virus 66 Int J Radiat Oncol 66 Pancreatic 66 Initiate Clinical Trial 66 Biosynthetic 66 Help Diagnose 66 Liver Cirrhosis 66 BioSante Pharmaceuticals Announces 66 Genotypes 66 Neurosci 66 Prostate Cancer Patients 66 NICE Recommends 66 Upregulation 66 Nerve Cell 66 Left Ventricular Hypertrophy 66 PEGylated Fab fragment 66 Asthma Treatment 66 Sevelamer 66 Metastatic Cancer 66 Granted Orphan Drug 66 Pregnancy Linked 66 Cell Differentiation 66 Hormonal Therapy 66 Treatment Naive 66 R brand levalbuterol 66 Cardiol 66 Pinpointed 66 Adiposity 66 Cognitive Function 66 Colon Polyps 66 Kinase Inhibitors 66 Protects Against 66 Nitric Oxide Synthase 66 Clin Oncol 66 Investigational Oral 66 Preterm Delivery 66 Pulsatile 66 Heart Circ Physiol 66 Helps Predict 66 Confirms Efficacy 66 Endometrial Cancer 66 Bacterial Cell 66 Fulvestrant 66 Water Soluble 66 Angiotensin Converting Enzyme 66 Tumor Necrosis Factor 66 Potent Anti 66 Progressive Multifocal Leukoencephalopathy 66 Oral Formulation 66 Gastric Ulcers 66 Liposomal 66 Non Alcoholic Fatty 66 Novel Approach 66 Cardiovasc 66 Am J Obstet 66 Prostate Cancer Progression 66 Analogues 66 Venous Thromboembolism 66 FASEB J. 66 Isavuconazole 66 #:#-# [020] 66 Hip Fractures 66 Anthrax Toxin 66 Vaccine Protects Against 66 Cholesterol Drug 66 Cytarabine 66 Enalapril 66 Effective Than 66 Hormone Therapy 66 Menopausal Women 66 C Reactive Protein 66 entitled Compositions 66 monocyte chemotactic protein 66 Cytoplasmic 66 Imaging Techniques 66 Subclinical 66 Chronic Pelvic Pain 66 Virus Infection 66 Initiates Phase 66 beta. 66 Novel Small Molecule 66 Immunomedics Announces 66 Tumor Progression 66 Pancreatic Islet 66 Physician Insights 66 Preclinical Evaluation 66 #:#-# [033] 66 Hormone Levels 66 Drug Induced 66 Tricyclic 66 Vaccine Candidate 66 Apoptotic 66 Genetic Predisposition 66 Prodrug 66 Lipid Metabolism 66 Hemolysis 66 TNF Alpha 66 Preclinical Models 66 Calcium Supplements 66 Neuroendocrine Tumors 66 Acute Pancreatitis 66 Bicalutamide 66 Sangamo BioSciences Announces 66 Metastatic Melanoma 66 Clinical Trial Data 66 Nebulized 66 Rheumatoid 66 #:#-# [035] 66 Neuroprotective 66 J Cataract Refract 66 Parenteral Nutrition 66 Antitumor activity 66 deaminase 66 Fatty Acids 66 Tipranavir 66 Platelet Function 66 Highly Sensitive 66 Orthostatic Hypotension 66 Combination Clinical Trial 66 Initiates Enrollment 66 Watchful Waiting 66 Premature Infants 66 Certain Cancers 66 Melphalan 66 Hepatocytes